CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities:
Net loss	$ (195,754)	$ (4,829)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	17,274	9,701
Amortization of debt issuance costs and discount on convertible debt	10,130	5,398
Stock-based compensation	4,588	410
Impairment of property, plant and equipment, intangible assets and goodwill	112,270	0
Loss (gain) on extinguishment of debt	14,610	(151)
Loss from equity investment	0	561
Gain on consolidation of equity investment	0	(640)
Loss on deconsolidation of subsidiary	37,708	0
Gain on fair value of warrant liabilities	(190)	(1,447)
Gain on fair value of derivative liability	(6,893)	(49,885)
Loss on disposal of property and equipment	0	80
Deferred income taxes	(17,485)	(1,274)
Other	0	350
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	(5,201)	(27,550)
Inventories	(126)	(326)
Prepaid expenses and other current assets	(592)	(1,050)
Accounts payable and accrued expenses	10,475	16,467
Income taxes payable	(758)	886
Deferred revenue	2,382	4,643
Due to related parties	(39)	17
Other liabilities	49	230
Net cash used in operating activities	(17,551)	(48,409)
Investing activities:
Purchases of property and equipment	(5,238)	(1,879)
Due to (from) related parties	(14)	253
Decondolidated Glocal cash (Note 1)	(8,743)	0
Net cash acquired in acquisition of businesses	0	4,263
Net cash (used in) provided by investing activities	(13,995)	2,637
Financing activities:
Proceeds from merger and recapitalization transaction	0	83,435
Proceeds from debt	67,500	164,500
Repayments of debt	(48,234)	(23,307)
Proceeds from Provider Relief Funds	0	506
Payment of debt issuance costs	(1,475)	(8,100)
Repayment of forward share purchase	(18,521)	0
Repayments of seller notes	(18,680)	(99,207)
Payments of capital lease obligations	(2,544)	(1,253)
Proceeds from stock option exercises	0	319
Payments for taxes related to net settlement of equity awards	(95)	0
Distribution to noncontrolling interest	(139)	(100)
Payments of amount due to member	0	(4,271)
Net cash (used in) provided by financing activities	(22,188)	112,522
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(459)	(807)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(54,193)	65,943
Cash, cash equivalents, and restricted cash, beginning of period	76,801	2,369
Cash, cash equivalents, and restricted cash, end of period	22,608	68,312
Supplemental cash flow information:
Cash paid for interest	5,269	4,640
Cash paid for income taxes	521	0
Property, plant and equipment reclassed from other assets	3,751	0
Property and equipment acquired through capital lease and vendor financing arrangements	3,005	1,047
Issuance of common stock for debt conversion	0	1,879
Issuance of common stock for debt issuance costs	713	0
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	22,608	67,877
Restricted cash	0	435
Total cash, cash equivalents, and restricted cash	22,608	68,312
TTC
Issuance of common stock and promissory note to consummate business combination	0	34,954
Glocal
Issuance of common stock and promissory note to consummate business combination	0	110,122
Innovations Group
Issuance of common stock and promissory note to consummate business combination	0	157,878
Cloudbreak
Issuance of common stock and promissory note to consummate business combination	$ 0	$ 106,298